ALISO VIEJO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today reported financial results for the quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights Total revenue
ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight’s
ALISO VIEJO, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., today announced that it will report financial results for the third quarter of 2026 after the market close on Tuesday, November 3,
ALISO VIEJO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced the appointments of Taryn Conway as Chief Commercial Officer and Frank Shields as Executive Vice President of Sales
Seattle, WA, Oct. 16, 2026 (GLOBE NEWSWIRE) -- K2 Vision has performed 5,000 Light Adjustable Lens (LAL) procedures. RxSight, the company that makes the lens, has recognized K2 Vision as the highest-volume LAL
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026,
ALISO VIEJO, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today reported financial results for the quarter ended June 30, 2026, and provided an update on its 2026 financial outlook. Second
ALISO VIEJO, Calif., July 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced that on July 24, 2026, RxSight granted inducement stock options to purchase a total of 571,286 shares of RxSight’s
ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it is investigating potential claims against the board of directors of RxSight, Inc. ("RxSight" or the
Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) concerning whether the board
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) concerning whether the board breached its
ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline,
Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologiesCollaboration aims to combine best-in-class PCIOL optics with first-in-class platform
Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies
Collaboration aims to combine best-in-class PCIOL optics with first-in-class
